Circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—may help risk-stratify patients with ...
MIAMI, FLORIDA (OCT. 20, 2025) – A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for patients with advanced neuroendocrine tumors ...
According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...